Exchange: NASDAQ·Updated 04:51 AM EDT
LIMN logo

LIMN Liminatus Pharma Inc.

$3.05
$0.06
(1.93%)
Pre-Market
Prev Close $3.11
Mkt Cap$4.08M
Vol4.00

About LIMN

Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
50

Neutral Sentiment

How do you feel about LIMN?

Unchanged1776
$LIMN called it to start making a move a week or so ago and it’s been compounding marginal daily gains ever since
3
Oilpatch1
$LIMN boy o boy. Looks like diamond ballz live rent free on this board. I have a suggestion for. Don't spend more than you can afford to lose. Lol.
2

Advertisement|Remove ads.